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cally normal coronary arteries were designated as the DM group. All 16 patients were taking sulfonylurea, but none was being treated with insulin. Diabetic retinopathy was diagnosed by 2 ophthalmologists in the hospital who were unaware of the coronary artery data. Thirteen non-DM neurosurgical patients with angiographically normal coronary arteries who underwent coronary angiography (CAG) for atypical chest pain, and who were referred for TEDE for preoperative exclusion of a patent foramen ovale comprised the control group. Selective CAG was performed by the Judkins technique (transradial approach) using a 4F CAG catheter (FansacIV, Clinical Supply Co, Ltd), and stenosis severity was judged by 2 experienced investigators from multiple projections stored on cineangiograms. Exclusion criteria were: history of myocardial infarction, valvular disease, left ventricular hypertrophy (wall thickness >11 mm), and reduced left ventricular function (ejection fraction (EF) <50%). The study protocol was in accordance with the guidelines of the institutional ethics committee and all patients gave written informed consent.
Echocardiography
Before CAG, TTE was performed in all patients to evaluate EF, wall thickness and left ventricular end-diastolic diameter. Within 1 week of CAG, all patients underwent TEDE performed after local anesthesia of the oropharynx with lidocaine, and using routine sedation (intravenous injection of 2 -3 mg propofol (AstraZeneca Pharmacy)). An intravenous cannula was placed into an antecubital vein to inject the contrast agent (Levovist; Schering and Tanabe Pharmacy), which was prepared at a microbubble concentration of 200 mg/ml. The surface ECG was monitored, and noninvasive blood pressure measurements were performed during echocardiography.
CSF Using Contrast-Enhanced TEDE
To obtain CSF recordings, the transesophageal probe was advanced to the gastric level and then, with dorsal angulation of the transducer, the probe was cautiously withdrawn until a modified 4-chamber view with visualization of the coronary sinus near its ostium into the right atrium was achieved. The transducer position was then optimized to obtain an angle of <30°between the Doppler beam and the long axis of the coronary sinus, and to achieve continuous visualization of the vessel throughout the cardiac cycle. Flow recordings were performed after placement of a sample volume into the coronary sinus no more than 1.5 cm from its ostium (Fig 1) . Up to 5 consecutive attempts were undertaken to obtain optimal flow recordings. Recordings were repeated until at least 3 consecutive flow velocity curves of similar appearance were achieved. After baseline recordings, adenosine triphosphate (ATP) (0.15 mg·kg -1 · min -1 ) was continuously infused for 5 min, during which time the CSF velocity recordings were repeated. Doppler velocity curves of optimal signal quality were evaluated, and measurements obtained from 3 cardiac cycles were averaged after bolus injection of Levovist (200 mg/ml, 2 ml). One experienced investigator who was unaware of the other patient's data analyzed each study. Measurements included maximum antegrade flow velocity (systolic (S) and diastolic phase (D), respectively) and antegrade flow velocity time integral (AVTI), and maximal coronary sinus dimension. For all measurements, 2 different methods with or without Levovist for the calculation of CFR were used to evaluate the usefulness of contrast. CFR was determined by dividing AVTI after ATP administration by AVTI at baseline (Fig 2) .
Reproducibility of CFR Data
We determined intraobserver and interobserver variabilities for measuring CFR by measuring the 2 variables in 10 randomly selected records twice by the same observer and by 2 independent observers, respectively. Intraobserver and interobserver variabilities of CFR were 6.1±6.3% and 7.0±6.0% (absolute difference), respectively.
Statistical Analysis
Results are expressed as mean values ± SD. An analysis of variance with subsequent Scheffe's F test and Fisher's exact probability test was performed to compare the Doppler parameters and clinical data of the DM group and control group. Two-way ANOVA was used to compare data before and after ATP administration. To analyze the predictive value of detecting diabetic microvascular dysfunction using the CFR of CSF, we constructed receiver-operating characteristic (ROC) curves, 15 and determined that a suitable cutoff point would be when sensitivity was as nearly equal to specificity as possible. A p-value <0.05 was considered statistically significant.
Results
Echocardiographic and Clinical Data
All patients were in sinus rhythm. In the DM group, 7 patients had background retinopathy, and the other 9 had preproliferative retinopathy. As shown in Table 1 fasting blood glucose and glycohemoglobin A1c levels were significantly higher in the DM group than in the control group. Compared with the control group, there were no significant differences in the DM group with regard to age, various echocardiographic parameters including EF, wall thickness, and left ventricular diastolic dimension, and the rates of hypertension and hypercholesterolemia.
Usefulness of Levovist to Detect Doppler Envelope
Overall, adequate CSF velocity could be obtained in 27 (93%) of 29 consecutive patients at baseline and it could be obtained in 25 (86%) of 29 patients during ATP stress measurements. However, with Levovist, adequate CSF velocity could be obtained in all patients at both baseline and during stress measurements. Representative results of CSF measurements with and without Levovist are shown in Fig 3. In 25 of the total study group, whose CSF velocity could be measured with and without Levovist at both rest and during stress, S, D, and AVTI with Levovist were significantly higher than the values in patients without Levovist at rest (S: 30±17 vs 27±17; D: 37±24 vs 33±23; AVTI: 82±28 vs 67±28; all p<0.01), and these results were similar under stress (S: 35±15 vs 30±15; D: 43±19 vs 38±18; AVTI: 147± 35 vs 123±29; all p<0.01). Fig 2 shows representative cases of CSF velocity recordings in the DM and control groups. CFR using CSF in DM was lower than that in the controls. Table 2 shows the effects of ATP administration on various hemodynamic and echocardiographic parameters during CSF measurements using contrast-enhanced TEDE. ATP significantly increased the heart rate in both groups while blood pressure remained unchanged. The maximal diameter of the coronary sinus remained unchanged after ATP infusion. ATP significantly increased D and AVTI in both groups but did not affect the other CSF parameters. D and AVTI after ATP infusion in DM group were significantly lower than in the control group. As a result, CFR in the DM group was significantly lower than in the control group (Fig 4: 1.4±0.4 vs 2.1±0.5; p<0.01). Using a ROC curve, 15 we considered the optimal cut-off point of CFR for detecting diabetic microvascular dysfunction to be around 1.7, because it had a sensitivity of 82% and specificity of 83% to detect diabetic microvascular dysfunction.
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Discussion
The present study results indicate that contrast-enhanced TEDE measurements of CFR using CSF can be evaluated easily and noninvasively, and that global CFR is significantly reduced in patients with type 2 DM and retinopathy. The retinal circulation provides an opportunity to noninvasively explore the relationship of systemic microvascular disorders. 16 Signs of retinopathy are structural markers of microvascular dysfunction caused by various processes, including diabetes, 17 and have been found to predict incident coronary heart disease. 18 Thus, in this study, we defined the patients with diabetic microvascular dysfunction as those with diabetic retinopathy but without significant epicardial coronary artery stenosis.
Compared with previous studies of the CFR of patients with DM using either a Doppler guide wire 1, 2, 19 or pressurewire, 20, 21 contrast-enhanced TEDE measurements can be done noninvasively. TEDE can make some patients uncomfortable, but this can be relieved by sedation. We evaluated the CFR of the entire coronary artery system, whereas in the previous study the CFR of only the LAD was evaluated using an invasive Doppler guidewire or TTE. 9 In cardiac disease with diffuse reduction of CFR (eg, diabetic microvascular dysfunction), evaluation of the global flow reserve by coronary sinus techniques may be more appropriate. There are reports that noninvasive measurement of flowmediated dilation (FMD) of the brachial arteries can detect diabetic cardiovascular dysfunction; 22, 23 however, the CFR of CSF is superior to FMD for evaluation of diabetic cardiovascular dysfunction because it directly reflcts cardiac function directly as compared with FMD and moreover the measurement of FMD can be difficult. 24 One of the major factors causing reduced CFR in DM is microvascular dysfunction, 19 and it can induce left ventricular dysfunction and heart failure, 16 as well as being related to coronary atherosclerosis. 18 DM is a major coronary risk factors so early detection of coronary arterial abnormality and preventing coronary atherosclerosis are important in the management of DM. Thus, we believe that contrastenhanced TEDE measurements of CFR in patients with DM is useful for preventing heart failure and coronary artery disease.
Compared with previous data about CFR, 2,25 the present values were lower, possibly because of differences between the CFR of CSF and that of each coronary artery, 9 as well as differences in methodology. In fact, the other report of CFR using CSF also had lower values as compared with CFR measured using Doppler guidewire. 2, 13 Moreover, Kornzon et al 26 have shown that the coronary sinus crosssectional area varies in size and shape during the cardiac cycle, which may also explain why our CFR values were lower than the previous reports.
Recently, various conditions, including hypertension, 27 left ventricular hypertrophy, 28 valvular disease, 28 and the postmenopausal state, 31, 32 have been reported to reduce CFR. As shown in Table 1 , in the present study there were no significant differences in the rates of hypertension and hypercholesterolemia, or left ventricular wall thickness measured by echocardiography between patients with and without DM. Moreover, we excluded left ventricular hypertrophy >11 mm, which included cases of hypertrophic cardiomyopathy, and all of the female study subjects were postmenopausal. Thus, the direct effects of these various factors on CFR can be considered as negligible in this study.
As shown in Fig 3, before injection of Levovist, in approximately 10% of patients, we could not clearly evaluate the Doppler envelope of CSF. However, after injection of Levovist, thorough and accurate evaluation of CSF was achieved in all patients. With respect to coronary artery flow, some studies have demonstrated that Levovist increases the feasibility and quality of transesophageal Doppler recordings. 33, 34 Thus, evaluation of CSF using TEDE can be considerably improved by injecting a small amount of Levovist.
Study Limitations
First, this study had a small sample size and moreover, as shown in Fig 4, there was a relative overlap of the DM and control groups. However, CFR of 1.7 in this study was a useful cut-off value for detecting diabetic microvascular dysfunction. Thus, we believe that this method can be used in the clinical setting. Second, TEDE can be an uncomfortable and semi-invasive examination; however, by sedating all patients who underwent TEDE there were no complaints of discomfort during the procedure. Although there are potential negative inotropic effects of propofol, it clearly did not affect blood pressure or systolic cardiac function as evaluated by TEDE. Thus, the influence of the sedative on CFR in this study can be discounted. Third, a change in the coronary sinus dimensions throughout the cardiac cycle can affect the measurements of CFR, but in our study, there were no significant differences between the 2 groups in the maximal coronary sinus dimension at baseline and during ATP administration (Table 2) . Therefore, that effect on the measurements was weak in this study. Finally, we did not compare our data with that obtained using the nuclear method 35, 36 that is widely used to noninvasively determine the functional severity of coronary lesions. However, the nuclear methods are usually used as regional cardiac assessments with some underestimation. CFR using CSF may be better for a global cardiac evaluation, such as for assessing diabetic microvascular dysfunction.
Conclusions
Contrast-enhanced TEDE measurement of CFR using CSF was able to evaluate diabetic microvascular dysfunction noninvasively. This technique can be used to identify patients with DM who may have a worse prognosis despite having normal left ventricular function and a normal epicardial coronary artery.
